1[1]Castella E, Ariza A, Fernandez-Vasalo A et al. Expression of CD44H and CD44V3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma. J Clin Pathol, 1996;49:489～92
2[2]Paradis V, Eschwege P, Loric S et al. De novo expression of CD44 in prostate carcinoma is correlated with systemic dissemination of prostate cancer. J Clin Pathol, 1998;51:798～802
3[3]Thomas I, Byers HR, Vink J et al. CD44 regulates tumor cell migration on hyalonate coated substrate. J Cell Biol, 1992;118:971～7
4[4]Friedrichs K, Franke F, Lisbos BW et al. CD44 isoforms correlate with celluar differentiation but not prognosis in human breast cancer. Cancer Res, 1995;55:5424～33
5[5]Charpin C, Garcia S, Bouvier C et al. Automated and quantitative immunocytochemical assays of CD44V6 in breast carcinomas. Hum Pathol, 1997;28:289～96
6[6]Joensuu H, Klemi PJ, Toikkanen S et al. Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol, 1993;143:867～74
